Delex Healthcare Group Overview
Get informed when a big investor buys or sells
+ Follow26.54%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Delex Healthcare Group (DELX) currently reports a ROE of 26.54%. That is above the sector sector average of 11.64%. Use the charts on this page to explore Delex Healthcare Group's ROE history and peer comparisons.
Delex Healthcare Group's ROE of 26.54% is higher than the its sector sector average of 11.64%. That is roughly 128.1% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Delex Healthcare Group's current 26.54% should be judged against industry norms (sector average: 11.64%) and against DELX's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 26.54%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 11.64%. From there, open related valuation or income-statement pages for Delex Healthcare Group, and consider following DELX for alerts when major investors trade the stock.
